Production of hybridomas secreting monoclonal antibodies against the lympholine osteoclast activating factor.

The human lympholine osteoclast activating factor (OAF) is thought to be involved in several bone-destroying diseases. The current studies were designed to produce monoclonal antibodies against OAF for use in the subsequent design of immunoassays for OAF in clinical samples. Spleen cells from mice i...

Description complète

Détails bibliographiques

Publié dans:	J Clin Invest
Auteurs principaux:	Luben, R A, Mohler, M A, Nedwin, G E
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Clinical Investigation 1979
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC372124/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/221547/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI109459
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!